abiogen.it
Develops, manufactures and markets pharmaceutical treatments for patients and healthcare providers in Italy and international markets
Highlights
- New on EvolcAdded 2026-11-02
About abiogen.it
Abiogen Pharma develops, manufactures and commercializes medicines in primary care and rare-disease areas. Its therapeutic areas include bone metabolism, vitamin D deficiency, pain, viscosupplementation, dermatology, respiratory diseases and diabetology.
The company serves healthcare professionals and patients through products marketed in Italy and internationally, as well as licensing and manufacturing activities.
Founded in 1997, Abiogen Pharma is based in Pisa, Italy. Its business has a history spanning more than a century and is family-run across five generations.
Product: Pharmaceutical products and treatments, with licensing and manufacturing services.
Jobs at abiogen.it
More biotech & pharma companies
arcangea.it
Italian manufacturer of herbal remedies and food supplements based on medicinal plants, sold to consumers and therapistsNew on EvolcCellply
Automated cell-therapy analysis platforms for biopharma companies and research institutesdulco.it
Dulco laxatives for constipation relief in sachets, solutions, tablets and suppositories, for consumers in ItalyNew on Evolcfarmagalenica.it
Galenic (magistral) drug compounding in partner Italian pharmacy labs, for patients, doctors and pharmacistsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Privacy & consent
- CookiebotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.